MTOR and hepatocellular carcinoma: Research has shown that upregulation of PTTG1 expression promotes transcriptional activation of asparagine synthetase (ASNS), a key activator of Asn metabolism, enhancing Asn metabolism and activating mTOR pathway to promote progression of hepatocellular carcinoma (68).